Kim Midwood
BSc (Hons), PhD
Professor of Matrix Biology
Professor Kim Midwood graduated with a B.Sc. (HONS) in Biochemistry from Edinburgh University in 1995. She completed her Ph.D. in the Department of Pathology at Edinburgh University in 1999, focusing on how changes in the extracellular matrix affect cellular signalling pathways in arthritis. She undertook postdoctoral training in the lab of Professor Jean Schwarzbauer, at Princeton University from 1999, continuing her work investigating the molecular mechanisms by which the cellular environment defines cell phenotype.
In 2004 she established the Matrix Immunology group in the Kennedy Institute of Rheumatology at Imperial College London, moving to Oxford University in 2011.
In 2007 she won an MRC New Investigators Award and in 2012 an Arthritis Research UK Senior Fellowship.
She founded the BioTech company Nascient Ltd in 2012.
Recent publications
-
Tracing the origins of lung fibrosis.
Journal article
Buckley CD. and Midwood KS., (2024), Nat Immunol
-
Extracellular matrix complexity in Q1
biomarker studies: a novel assay Q2
detecting total serum tenascin-C
reveals different distribution to
isoform-specific assays
Journal article
MIDWOOD KIM., (2023), Frontiers in Immunology
-
Chemokine binding to tenascin-C influences chemokine-induced immune cell migration
Journal article
MIDWOOD KIM., (2023), IJMS
-
Investigating chemokine-matrix networks in breast cancer: tenascin-C sets the tone for CCL2
Journal article
MIDWOOD KIM., (2023), IJMS
-
Tenascin-C is a driver of inflammation in the DSS model of colitis
Journal article
MIDWOOD KIM., (2022), Matrix Biology Plus